ProfileGDS5678 / 1450738_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 11% 12% 12% 12% 12% 13% 13% 22% 14% 13% 12% 12% 12% 12% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3054211
GSM967853U87-EV human glioblastoma xenograft - Control 22.3050912
GSM967854U87-EV human glioblastoma xenograft - Control 32.3121812
GSM967855U87-EV human glioblastoma xenograft - Control 42.2473612
GSM967856U87-EV human glioblastoma xenograft - Control 52.2565512
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3693313
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3458513
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4925422
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3178414
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.301913
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2978312
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2719712
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2954512
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2952212